Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Antonina Naskalska"'
Autor:
Monika Janik, Tomasz Gabler, Marcin Koba, Mirosława Panasiuk, Yanina Dashkevich, Tomasz Łęga, Agnieszka Dąbrowska, Antonina Naskalska, Sabina Żołędowska, Dawid Nidzworski, Krzysztof Pyrć, Beata Gromadzka, Mateusz Śmietana
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Accurate and fast detection of viruses is crucial for controlling outbreaks of many diseases; therefore, to date, numerous sensing systems for their detection have been studied. On top of the performance of these sensing systems, the availab
Externí odkaz:
https://doaj.org/article/d1405b8da10e4e00a3ac4208d209f6be
Publikováno v:
Communications Materials, Vol 3, Iss 1, Pp 1-9 (2022)
Virus-like particles are promising for drug delivery systems and vaccine development, but controlling their size and morphology is challenging. Here, amino acid sequences are inserted into MS2 bacteriophage virus-like particles, with their size and s
Externí odkaz:
https://doaj.org/article/1855ba0c2f854e1c8fa48d4625a75d6a
Autor:
Antonina Naskalska, Agnieszka Dabrowska, Artur Szczepanski, Krzysztof P. Jasik, Beata Gromadzka, Krzysztof Pyrc
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a major epidemic threat since the beginning of 2020. Efforts to combat the virus and the associated coronavirus disease 2019 (COVID-19) disease are being undertaken worldwide. To fa
Externí odkaz:
https://doaj.org/article/324bb8faf15f465cb0ed5105d858088f
Autor:
Antonina Naskalska, Agnieszka Dabrowska, Paulina Nowak, Artur Szczepanski, Krzysztof Jasik, Aleksandra Milewska, Marek Ochman, Slawomir Zeglen, Zenon Rajfur, Krzysztof Pyrc
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203489 (2018)
Virus like particles (VLPs) produced by the expression of viral structural proteins can serve as versatile nanovectors or potential vaccine candidates. In this study we describe for the first time the generation of HCoV-NL63 VLPs using baculovirus sy
Externí odkaz:
https://doaj.org/article/1b41ae0b230c4101bce9314abe38be8a
Autor:
Ewa Szolajska, Wim P Burmeister, Monika Zochowska, Barbara Nerlo, Igor Andreev, Guy Schoehn, Jean-Pierre Andrieu, Pascal Fender, Antonina Naskalska, Chloe Zubieta, Stephen Cusack, Jadwiga Chroboczek
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e46075 (2012)
During the viral life cycle adenoviruses produce excess capsid proteins. Human adenovirus serotype 3 (Ad3) synthesizes predominantly an excess of free pentons, the complexes of pentameric penton base and trimeric fiber proteins, which are responsible
Externí odkaz:
https://doaj.org/article/394de866805e45adbb6eae6cefdfc308
Autor:
Joanna Jankowska-Śliwińska, Kamil Kosiel, Maciej Kozubal, Anna Szerling, Krzysztof Zaraska, Krzysztof Grabczewski, Piotr Polak, Renata Kruszka, Laura Stanco, Anna Niedzwiecka, Antonina Naskalska, Agnieszka Dabrowska, Krzysztof Pyrc
Publikováno v:
Quantum Sensing and Nano Electronics and Photonics XIX.
Autor:
Elżbieta Pyza, Izabela Stupka, Antonina Naskalska, Jan Różycki, Kinga Borzęcka-Solarz, Jonathan G. Heddle, Michał Bochenek
Publikováno v:
Biomacromolecules
Artificial protein cages have potential as programmable, protective carriers of fragile macromolecules to cells. While natural cages and VLPs have been extensively exploited, the use of artificial cages to deliver active proteins to cells has not yet
Publikováno v:
Communications Materials, Vol 3, Iss 1, Pp 1-9 (2022)
Virus-like particles (VLPs) have significant potential as artificial vaccines and drug delivery systems. The ability to control their size has wide ranging utility but achieving such controlled polymorphism using a single protein subunit is challengi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7b9cd7aca97e34067004e6e09ee03e
https://eprints.whiterose.ac.uk/183013/3/s43246_022_00229_3.pdf
https://eprints.whiterose.ac.uk/183013/3/s43246_022_00229_3.pdf
Autor:
Paweł Mak, Magdalena Kulczycka, Aleksandra Milewska, Elftherios Diamandis, Antonina Naskalska, Adam Lesner, Krzysztof Pyrc, Ewa Bielecka, Marek Ochman, Maciej Urlik, Ioannis Prassas, Katherine Falkowski, Tomasz Kantyka, Jan Potempa
Publikováno v:
Science Signaling
The protease kallikrein 13 cleaves the spike protein of the human coronavirus HKU1 to facilitate viral entry.
Priming viral entry Unlike SARS-CoV-2, the human coronavirus HKU1 normally causes relatively mild respiratory tract infections; however
Priming viral entry Unlike SARS-CoV-2, the human coronavirus HKU1 normally causes relatively mild respiratory tract infections; however
Autor:
Marek Ochman, Antonina Naskalska, Jan Potempa, Katherine Falkowski, Magdalena Kalinska, Adam Lesner, Ewa Bielecka, Tomasz Kantyka, Krzysztof Pyrc, Aleksandra Milewska, Paweł Mak, Maciej Urlik
Human coronavirus HKU1 (HCoV-HKU1) is associated with respiratory disease and is prevalent worldwide, but in vitro model for virus replication is lacking. Interaction between the coronaviral spike (S) protein and its receptor is the major determinant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65ba32054c69cd61cf4924a3f601e72b
https://doi.org/10.1101/2020.03.01.971499
https://doi.org/10.1101/2020.03.01.971499